Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury

Simone E. Dekker, Vahagn C. Nikolian, Martin Sillesen, Ted Bambakidis, Patrick Schober, Hasan B. Alam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Traumatic brain injury (TBI) is a leading cause of death in young adults, and effective treatment strategies have the potential to save many lives. TBI results in coagulopathy, endothelial dysfunction, inflammation, cell death, and impaired epigenetic homeostasis, ultimately leading to morbidity and/or mortality. Commonly used resuscitation fluids such as crystalloids or colloids have several disadvantages and might even be harmful when administered in large quantities. There is a need for next-generation treatment strategies (especially in the prehospital setting) that minimize cellular damage, improve survival, and enhance neurological recovery. Pharmacologic treatment with histone deacetylase inhibitors, such as valproic acid, has shown promising results in animal studies of TBI and may therefore be an excellent example of next-generation therapy. This review briefly describes traditional resuscitation strategies for TBI combined with hemorrhagic shock and describes preclinical studies on valproic acid as a new pharmacologic agent in the treatment of TBI. It finally discusses limitations and future directions on the use of histone deacetylase inhibitors for the treatment of TBI.

Original languageEnglish
Pages (from-to)711-719
Number of pages9
JournalJournal of Neuroscience Research
Volume96
DOIs
Publication statusPublished - 2018

Cite this

Dekker, Simone E. ; Nikolian, Vahagn C. ; Sillesen, Martin ; Bambakidis, Ted ; Schober, Patrick ; Alam, Hasan B. / Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury. In: Journal of Neuroscience Research. 2018 ; Vol. 96. pp. 711-719.
@article{de82117597fe49b1aeaeb5279eac70f6,
title = "Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury",
abstract = "Traumatic brain injury (TBI) is a leading cause of death in young adults, and effective treatment strategies have the potential to save many lives. TBI results in coagulopathy, endothelial dysfunction, inflammation, cell death, and impaired epigenetic homeostasis, ultimately leading to morbidity and/or mortality. Commonly used resuscitation fluids such as crystalloids or colloids have several disadvantages and might even be harmful when administered in large quantities. There is a need for next-generation treatment strategies (especially in the prehospital setting) that minimize cellular damage, improve survival, and enhance neurological recovery. Pharmacologic treatment with histone deacetylase inhibitors, such as valproic acid, has shown promising results in animal studies of TBI and may therefore be an excellent example of next-generation therapy. This review briefly describes traditional resuscitation strategies for TBI combined with hemorrhagic shock and describes preclinical studies on valproic acid as a new pharmacologic agent in the treatment of TBI. It finally discusses limitations and future directions on the use of histone deacetylase inhibitors for the treatment of TBI.",
keywords = "Histone deacetylase inhibitor, Resuscitation, Traumatic brain injury, Valproic acid",
author = "Dekker, {Simone E.} and Nikolian, {Vahagn C.} and Martin Sillesen and Ted Bambakidis and Patrick Schober and Alam, {Hasan B.}",
year = "2018",
doi = "10.1002/jnr.24125",
language = "English",
volume = "96",
pages = "711--719",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",

}

Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury. / Dekker, Simone E.; Nikolian, Vahagn C.; Sillesen, Martin; Bambakidis, Ted; Schober, Patrick; Alam, Hasan B.

In: Journal of Neuroscience Research, Vol. 96, 2018, p. 711-719.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury

AU - Dekker, Simone E.

AU - Nikolian, Vahagn C.

AU - Sillesen, Martin

AU - Bambakidis, Ted

AU - Schober, Patrick

AU - Alam, Hasan B.

PY - 2018

Y1 - 2018

N2 - Traumatic brain injury (TBI) is a leading cause of death in young adults, and effective treatment strategies have the potential to save many lives. TBI results in coagulopathy, endothelial dysfunction, inflammation, cell death, and impaired epigenetic homeostasis, ultimately leading to morbidity and/or mortality. Commonly used resuscitation fluids such as crystalloids or colloids have several disadvantages and might even be harmful when administered in large quantities. There is a need for next-generation treatment strategies (especially in the prehospital setting) that minimize cellular damage, improve survival, and enhance neurological recovery. Pharmacologic treatment with histone deacetylase inhibitors, such as valproic acid, has shown promising results in animal studies of TBI and may therefore be an excellent example of next-generation therapy. This review briefly describes traditional resuscitation strategies for TBI combined with hemorrhagic shock and describes preclinical studies on valproic acid as a new pharmacologic agent in the treatment of TBI. It finally discusses limitations and future directions on the use of histone deacetylase inhibitors for the treatment of TBI.

AB - Traumatic brain injury (TBI) is a leading cause of death in young adults, and effective treatment strategies have the potential to save many lives. TBI results in coagulopathy, endothelial dysfunction, inflammation, cell death, and impaired epigenetic homeostasis, ultimately leading to morbidity and/or mortality. Commonly used resuscitation fluids such as crystalloids or colloids have several disadvantages and might even be harmful when administered in large quantities. There is a need for next-generation treatment strategies (especially in the prehospital setting) that minimize cellular damage, improve survival, and enhance neurological recovery. Pharmacologic treatment with histone deacetylase inhibitors, such as valproic acid, has shown promising results in animal studies of TBI and may therefore be an excellent example of next-generation therapy. This review briefly describes traditional resuscitation strategies for TBI combined with hemorrhagic shock and describes preclinical studies on valproic acid as a new pharmacologic agent in the treatment of TBI. It finally discusses limitations and future directions on the use of histone deacetylase inhibitors for the treatment of TBI.

KW - Histone deacetylase inhibitor

KW - Resuscitation

KW - Traumatic brain injury

KW - Valproic acid

UR - http://www.scopus.com/inward/record.url?scp=85026385660&partnerID=8YFLogxK

U2 - 10.1002/jnr.24125

DO - 10.1002/jnr.24125

M3 - Article

VL - 96

SP - 711

EP - 719

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

ER -